The LINC00330/CCL2 axis can block the CCL2/CCR2 axis and its downstream signaling pathways through the autocrine pathway and inhibit the secretion of CCL2 through the paracrine pathway, mediate TAM reprogramming, and inhibit ESCC progression. This evidence concerns the gene LINC00330 and esophageal squamous cell carcinoma.